Search by Drug Name or NDC

    NDC 11673-0763-40 up and up nighttime severe cold and flu 650; 20; 12.5; 10 mg/30mL; mg/30mL; mg/30mL; mg/30mL Details

    up and up nighttime severe cold and flu 650; 20; 12.5; 10 mg/30mL; mg/30mL; mg/30mL; mg/30mL

    up and up nighttime severe cold and flu is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by Target Corporation. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 11673-0763
    Product ID 11673-763_3eb8cd3a-6c86-4ef0-98a3-095375bd17a6
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name up and up nighttime severe cold and flu
    Proprietary Name Suffix n/a
    Non-Proprietary Name Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine Succinate, Phenylephrine Hydrochloride
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 650; 20; 12.5; 10
    Active Ingredient Units mg/30mL; mg/30mL; mg/30mL; mg/30mL
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Target Corporation
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Antihistamine [EPC], Histamine Receptor Antagonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 11673-0763-40 (11673076340)

    NDC Package Code 11673-763-40
    Billing NDC 11673076340
    Package 355 mL in 1 BOTTLE (11673-763-40)
    Marketing Start Date 2020-03-17
    NDC Exclude Flag N
    Pricing Information N/A